菌体作为疫苗平台:翻译的机遇和挑战
Wangxue Chen1,2, Danielle L Peters1, Serena Lam1,3
1Human Health Therapeutics (HHT) Research Center, National Research Council Canada, Ottawa, ON, Canada.
Human vaccines & immunotherapeutics
|December 16, 2025
概括
菌体 (菌体) 作为下一代疫苗平台具有前景,因为它们的安全性,成本效益以及引起强烈免疫反应的能力. 需要进一步的研究和临床试验才能充分发挥其在应对全球卫生挑战方面的潜力.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 微生物学 微生物学
- 生物技术是生物技术.
背景情况:
- 菌体 (菌体) 正在作为疫苗开发的多功能候选物获得关注.
- 它们的固有特征,包括基因操纵性和抗原显示,使它们成为有吸引力的平台.
- 现有的食品和同情性菌体治疗的监管批准支持其发展.
研究的目的:
- 总结目前针对各种目标的菌体疫苗开发的进展.
- 讨论与这个创新的疫苗平台相关的承诺和挑战.
- 突出菌体疫苗在解决抗菌素耐药性和流行病准备方面的潜力.
主要方法:
- 审查关于菌体基础疫苗策略和进展的现有文献.
- 对疫苗开发相关的菌体特征的分析 (例如,免疫性,安全性,生产).
- 讨论菌体疫苗诱导的免疫反应的实验数据.
主要成果:
- 基于菌体的疫苗表现出易于基因操纵,高密度抗原显示和免疫刺激性质.
- 它们的生产成本高效,稳定,并且表现出与其他平台相比的免疫反应.
- 实验数据证实了特定细胞,幽默和粘膜免疫反应的诱导.
结论:
- 基于菌体的疫苗代表了一个具有重大潜力的创新平台,可以应对诸如抗菌素耐药性和流行病等公共卫生挑战.
- 进一步了解菌体生物学,严格的临床前研究和临床试验对于全面实现至关重要.
- 发展需要改善良好的制造实践生产和明确的监管框架.
相关概念视频
Lytic Cycle of Bacteriophages
77.3K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.3K
DNA Bacteriophages
744
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
744
Microorganisms in Medicine and Therapeutics
914
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
914
Lysogenic Cycle of Bacteriophages
67.2K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.2K
Viral Replication: Lysogenic Cycle
1.2K
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
1.2K
Viral Replication: Lytic Cycle
1.1K
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
1.1K


